Geyer Philipp E, Hornburg Daniel, Pernemalm Maria, Hauck Stefanie M, Palaniappan Krishnan K, Albrecht Vincent, Dagley Laura F, Moritz Robert L, Yu Xiaobo, Edfors Fredrik, Vandenbrouck Yves, Mueller-Reif Johannes B, Sun Zhi, Brun Virginie, Ahadi Sara, Omenn Gilbert S, Deutsch Eric W, Schwenk Jochen M
Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany.
Seer, Inc., Redwood City, California 94065, United States.
J Proteome Res. 2024 Dec 6;23(12):5279-5295. doi: 10.1021/acs.jproteome.4c00586. Epub 2024 Oct 31.
Recent improvements in proteomics technologies have fundamentally altered our capacities to characterize human biology. There is an ever-growing interest in using these novel methods for studying the circulating proteome, as blood offers an accessible window into human health. However, every methodological innovation and analytical progress calls for reassessing our existing approaches and routines to ensure that the new data will add value to the greater biomedical research community and avoid previous errors. As representatives of HUPO's Human Plasma Proteome Project (HPPP), we present our 2024 survey of the current progress in our community, including the latest build of the Human Plasma Proteome PeptideAtlas that now comprises 4608 proteins detected in 113 data sets. We then discuss the updates of established proteomics methods, emerging technologies, and investigations of proteoforms, protein networks, extracellualr vesicles, circulating antibodies and microsamples. Finally, we provide a prospective view of using the current and emerging proteomics tools in studies of circulating proteins.
蛋白质组学技术的最新进展从根本上改变了我们表征人类生物学的能力。人们对使用这些新方法研究循环蛋白质组的兴趣与日俱增,因为血液为了解人类健康提供了一个可及的窗口。然而,每一项方法创新和分析进展都要求我们重新评估现有的方法和流程,以确保新数据能为更广泛的生物医学研究界增添价值,并避免以往的错误。作为人类蛋白质组组织(HUPO)的人类血浆蛋白质组计划(HPPP)的代表,我们展示了我们2024年对本领域当前进展的调查,包括人类血浆蛋白质组肽图谱的最新版本,该图谱目前包含在113个数据集中检测到的4608种蛋白质。然后,我们讨论了既定蛋白质组学方法的更新、新兴技术,以及蛋白质异构体、蛋白质网络、细胞外囊泡、循环抗体和微量样本的研究。最后,我们对在循环蛋白质研究中使用当前和新兴蛋白质组学工具提供了前瞻性展望。